Celecoxib
Who holds supplier records for Celecoxib? 36 organisations hold a current record for Celecoxib: an active US FDA Type II Drug Master File or a CEP. A further 3 organisations have only historical (inactive) DMF filings. 26 of them hold a valid EU Certificate of Suitability (28 holder entries on the EDQM register, listed below). Recorded organisation countries for current records: India (22), China (8), Peru (1), Taiwan (1) and 3 other countries (3); not recorded for 1.
Sources: FDA Drug Master File list, EDQM certification database, FDA Orange Book. Record updated 16 Nov 2026. How we read these records
Cite as: PharmaTek, “Celecoxib: DMF and CEP holder records”, record as of 16 Nov 2026, pharmatek.co.uk/directory/api/celecoxib
Reading the evidence
- 36 current records
Several organisations hold current DMFs or CEPs. Whether any is a usable source for your grade, scale and market still needs qualification.
- Most recorded organisations are in India
22 of the 35 current records with a recorded country list India. Organisation country is not necessarily the manufacturing site.
- 20 with a company-level GMP certificate on record
These organisations have at least one current EU or UK GMP certificate somewhere. It is not matched to the site that makes this substance; check the certificate's site and scope.
- US product patents listed
The latest patent listed in the FDA Orange Book for an approved product containing Celecoxib expires 17 Sept 2045. Product, formulation and method-of-use patents do not by themselves stop the ingredient being supplied or other products being approved.
Current records (36)
Organisations holding an active US FDA Type II Drug Master File or a CEP for Celecoxib. Country is the organisation's recorded country, not necessarily the manufacturing site.
- MICRO LABS LTDIndiaCEP Company GMP cert on recordActive DMF 24686, 37290 · latest filing Jul 2022
- AARTI DRUGS LTDIndiaCEP Company GMP cert on recordActive DMF 23161 · latest filing Oct 2009
- Alembic Pharmaceuticals LimitedIndiaCEP Company GMP cert on recordActive DMF 24419 · latest filing Nov 2010
- APITORIA PHARMA PRIVATE LTDIndiaCEP Company GMP cert on recordActive DMF 27501 · latest filing Sept 2013
- Aurore Life SciencesIndiaCEP Company GMP cert on recordActive DMF 34070 · latest filing Aug 2019
- Cadila Pharmaceuticals LimitedIndiaCEP Company GMP cert on recordActive DMF 19155 · latest filing Jan 2006
- Cipla LimitedIndiaCEP Company GMP cert on recordActive DMF 16671 · latest filing Jun 2003
- HENAN DONGTAI PHARM CO LTDChinaCEPActive DMF 37092 · latest filing May 2022
- Hetero Drugs LimitedIndiaCEP Company GMP cert on recordActive DMF 24557 · latest filing Jan 2011
- HIKAL LTDIndiaCEP Company GMP cert on recordActive DMF 31971 · latest filing Jul 2017
- INTERQUIM SAPeruCEP Company GMP cert on recordActive DMF 26886 · latest filing Feb 2013
- Jiangxi Synergy Pharmaceutical Co., LtdChinaCEPActive DMF 25582 · latest filing Aug 2011
- Macleods Pharmaceuticals Ltd.IndiaCEP Company GMP cert on recordActive DMF 25792 · latest filing Jun 2012
- MATRIX PHARMACORP PRIVATE LTDIndiaCEPActive DMF 17697 · latest filing Sept 2004
- RAKS PHARMA PVT LTDIndiaCEPActive DMF 25636 · latest filing Dec 2011
- SCINOPHARM TAIWAN LTDTaiwanCEPActive DMF 30926 · latest filing Oct 2016
- AMOLI ORGANICS (A DIVISION OF UMEDICA LABORATORIES PVT LTD)IndiaActive DMF 25427 · latest filing Jan 2012
- CHEMECA DRUGS PRIVATE LTDIndiaActive DMF 37530 · latest filing Jan 2023
- Dr. Reddy's Laboratories Ltd.India Company GMP cert on recordActive DMF 21921 · latest filing Sept 2008
- Lupin LimitedIndia Company GMP cert on recordActive DMF 23543 · latest filing Apr 2010
- PHARMAZELL INDIA PRIVATE LTDIndia Company GMP cert on recordActive DMF 26356 · latest filing Aug 2012
- SAURAV CHEMICALS LTDActive DMF 27384 · latest filing Dec 2015
- SOLARA ACTIVE PHARMA SCIENCES LTDIndia Company GMP cert on recordActive DMF 28020 · latest filing Feb 2014
- TIANJIN TIANYAO PHARMACEUTICALS CO LTDChinaActive DMF 27635 · latest filing Mar 2015
- Unichem Laboratories Ltd.India Company GMP cert on recordActive DMF 33579 · latest filing Mar 2019
- Zhejiang Yongtai Pharmaceutical Co., Ltd.ChinaActive DMF 31101 · latest filing Dec 2016
- IndiaCEP
- IndiaCEP Company GMP cert on record
- IndiaCEP
- GermanyCEP Company GMP cert on record
- SpainCEP Company GMP cert on record
- Shandong Anxin Pharmaceutical Co., Ltd.ChinaCEP Company GMP cert on record
- ChinaCEP
- HARWAY PHARMA CO. LTD.ChinaCEPValid CEP holder (EDQM); not necessarily the manufacturer
- DONGBANG FUTURE TECH & LIFE CO., LTD.South KoreaCEPValid CEP holder (EDQM); not necessarily the manufacturer
- ZHEJIANG CHEMSYN PHARM. CO., LTD.ChinaCEPValid CEP holder (EDQM); not necessarily the manufacturer
The Sourcing Desk contacts candidates, confirms current supply, grade and site, and screens each against its regulatory record, for a buyer-paid fixed fee and never a supplier commission.
Valid CEP holder entries (28)
Certificates of Suitability on the EDQM register for Celecoxib, including the salts, esters and hydrates the register lists separately; each row shows the substance as named on the certificate. A CEP confirms the substance can be controlled by the European Pharmacopoeia monograph; it is not a GMP certificate, and the holder is not necessarily the manufacturer. 44 certificates in total, including withdrawn, expired, suspended and repeat certificates.
| Holder | Country | Certificate | Issued | EU GMP at holder's address |
|---|---|---|---|---|
| MATRIX PHARMACORP PRIVATE LIMITED Sangareddy | IN | CEP 2012-183 - Rev 07 Celecoxib | Nov 2026 | — |
| HARWAY PHARMA CO. LTD. Dongying | CN | CEP 2024-373 - Rev 00 Celecoxib | Sept 2026 | — |
| HETERO DRUGS LIMITED Hyderabad | IN | CEP 2016-037 - Rev 03 Celecoxib | Aug 2026 | — |
| AARTI DRUGS LIMITED Mumbai | IN | CEP 2014-199 - Rev 02 Celecoxib | Aug 2026 | — |
| INTERQUIM S.A. Sant Cugat Del Valles | ES | CEP 2026-220 - Rev 00 Celecoxib, Process 2 | Jul 2026 | Inspected Sept 2024 Spain |
| DONGBANG FUTURE TECH & LIFE CO., LTD. Hwaseong-Si | KR | CEP 2015-185 - Rev 01 Celecoxib | Mar 2026 | — |
| KEKULE PHARMA LIMITED Hyderabad | IN | CEP 2023-274 - Rev 01 Celecoxib, Micronised and non-micronised | Mar 2026 | — |
| AURORE LIFE SCIENCES PRIVATE LIMITED Hyderabad | IN | CEP 2023-194 - Rev 02 Celecoxib, Site Khazipally | Feb 2026 | — |
| ZHEJIANG CHEMSYN PHARM. CO., LTD. Quzhou | CN | CEP 2020-170 - Rev 01 Celecoxib | Sept 2025 | — |
| MICRO LABS LIMITED Bengaluru | IN | CEP 2012-286 - Rev 02 Celecoxib | Jul 2025 | — |
| ALEMBIC PHARMACEUTICALS LIMITED Vadodara | IN | CEP 2012-388 - Rev 04 Celecoxib | May 2025 | — |
| PHARMAZELL GMBH Raubling | DE | CEP 2012-151 - Rev 03 Celecoxib | Feb 2025 | Inspected Jun 2025 Germany |
| JIANGXI SYNERGY PHARMACEUTICAL CO., LTD. Yichun | CN | CEP 2024-468 - Rev 00 Celecoxib, Process II | Feb 2025 | — |
| HIKAL LIMITED Bangalore | IN | CEP 2017-199 - Rev 04 Celecoxib | Sept 2024 | Inspected Nov 2025 Switzerland |
| SCINOPHARM TAIWAN LTD. Shan-Hua | TW | CEP 2016-320 - Rev 01 Celecoxib | Sept 2024 | — |
| AMOLI ORGANICS PRIVATE LIMITED Mumbai | IN | CEP 2024-200 - Rev 00 Celecoxib, Process-III, Form-III | Aug 2024 | — |
| HENAN DONGTAI PHARM CO., LTD. Anyang City | CN | CEP 2022-283 - Rev 00 Celecoxib | May 2024 | — |
| IPCA LABORATORIES LIMITED Mumbai | IN | CEP 2023-325 - Rev 00 Celecoxib | May 2024 | — |
| APITORIA PHARMA PRIVATE LIMITED Hyderabad | IN | CEP 2012-320 - Rev 02 Celecoxib | Jan 2024 | — |
| MACLEODS PHARMACEUTICALS LIMITED Mumbai | IN | CEP 2015-195 - Rev 01 Celecoxib | Sept 2023 | — |
| CIPLA LIMITED Mumbai | IN | R1-CEP 2014-186 - Rev 01 Celecoxib | May 2023 | — |
| SHANDONG ANXIN PHARMACEUTICAL CO., LTD. Dongjia Town | CN | R1-CEP 2015-297 - Rev 01 Celecoxib | Aug 2022 | — |
| CADILA PHARMACEUTICALS LIMITED Ankleshwar | IN | R1-CEP 2015-220 - Rev 00 Celecoxib | May 2022 | — |
| QUIMICA SINTETICA S.A. Alcala De Henares | ES | R1-CEP 2016-160 - Rev 00 Celecoxib | Nov 2021 | — |
| Interquim, S.A. Sant Cugat Del Vallès | ES | R1-CEP 2012-351 - Rev 01 Celecoxib | Jul 2021 | — |
| ZENJI PHARMACEUTICALS (SUZHOU) LTD. Xuguan, Suzhou | CN | R1-CEP 2015-029 - Rev 00 Celecoxib | Mar 2021 | — |
| RAKS PHARMA PVT. LTD. Visakhapatnam | IN | R1-CEP 2013-317 - Rev 00 Celecoxib | Mar 2020 | — |
| JIANGXI SYNERGY PHARMACEUTICAL CO., LTD. Fengxin | CN | R1-CEP 2012-404 - Rev 00 Celecoxib | Jul 2019 | — |
The GMP column shows the most recent EU GMP certificate issued for the same address as the holder, joined on the EMA location identifier printed on both documents (EudraGMDP, re-read about once a quarter; withdrawn certificates are excluded). A dash means no certificate carries that identifier, not that the site is uninspected. The holder's address is not necessarily where the substance is made.
Certification Online Database. European Directorate for the Quality of Medicines & HealthCare (EDQM), Council of Europe, (2026), URL: https://extranet.edqm.eu/publications/recherches_CEP.shtml. Accessed 16 Nov 2026. Reproduced with permission and unaltered. The EDQM and the Council of Europe accept no liability for any consequence arising from its use.
Historical records (3)
Organisations whose Type II DMFs for Celecoxib are no longer active. These show a past filing, not current supply.
Show all 3 historical records
- HISUN PHARMACEUTICAL NANTONG CO LTDInactive DMF 27744 · filed Dec 2013
- China · Inactive DMF 27872 · filed Dec 2013
- Italy · Inactive DMF 19652 · filed Aug 2006
US product patents and exclusivity
The FDA Orange Book lists patents and exclusivities for specific approved products (73 listed products contain Celecoxib). The latest listed patent expires 17 Sept 2045. These dates are product-specific: they can cover a formulation, a combination or a method of use, and do not on their own show whether the ingredient is protected or whether generics are already approved. Check the individual product entries before planning a launch.
Overview
Celecoxib is a nonsteroidal anti-inflammatory drug (NSAID) that selectively inhibits cyclooxygenase-2 (COX-2), leading to decreased formation of prostaglandins involved in inflammation and pain. It is commonly used to treat conditions such as osteoarthritis, rheumatoid arthritis, and acute pain.
Chemical identity
- IUPAC name
- 4-[5-(4-methylphenyl)-3-(trifluoromethyl)pyrazol-1-yl]benzenesulfonamide
- Canonical SMILES
- CC1=CC=C(C=C1)C2=CC(=NN2C3=CC=C(C=C3)S(=O)(=O)N)C(F)(F)F
- InChIKey
- RZEKVGVHFLEQIL-UHFFFAOYSA-N
- Synonyms
- Celebrex API, celebrex, consensi component celecoxib, dfn-15, dfn15, elyxyb, nsc-719627, nsc-758624, onsenal, sc-58635
Pharmacologic class
As the US FDA states it for this active substance on product listings.
- Established pharmacologic class
- Nonsteroidal Anti-inflammatory Drug
- Mechanism of action
- Cyclooxygenase Inhibitors
- Chemical structure
- Non-Steroidal
Therapeutic areas
Record history
No change to the current records between 13 Nov 2026 and 16 Nov 2026.
Get an email when these records change: at most one a week, only when something changed, and only after you confirm your address. All changes this week
What these records establish
- An active DMF means a confidential file is held by the FDA and can be referenced; the FDA does not approve or disapprove DMFs.
- A CEP confirms monograph suitability for the EU market; it is not a GMP certificate, and the holder may not be the manufacturer.
- Historical records show a past filing, not current supply.
- Company GMP certificates are matched to the organisation, not to the site making this substance.
- A substance missing from these registers is not evidence that no supplier exists.
Frequently asked questions
Which organisations hold current supplier records for Celecoxib?
36 organisations hold an active US FDA Type II Drug Master File or a CEP for Celecoxib: MICRO LABS LTD (India), AARTI DRUGS LTD (India), Alembic Pharmaceuticals Limited (India), APITORIA PHARMA PRIVATE LTD (India), Aurore Life Sciences (India), Cadila Pharmaceuticals Limited (India), Cipla Limited (India) and HENAN DONGTAI PHARM CO LTD (China), and 28 more listed on this page. A DMF or CEP shows a regulatory filing, not current commercial availability, and the holder is not necessarily the manufacturing site.
Which Celecoxib Drug Master Files are active?
MICRO LABS LTD (DMF 24686, 37290), AARTI DRUGS LTD (DMF 23161), Alembic Pharmaceuticals Limited (DMF 24419), APITORIA PHARMA PRIVATE LTD (DMF 27501), Aurore Life Sciences (DMF 34070), Cadila Pharmaceuticals Limited (DMF 19155), Cipla Limited (DMF 16671) and HENAN DONGTAI PHARM CO LTD (DMF 37092) and 18 more. The FDA does not approve or disapprove DMFs; an active DMF can be referenced in an application once its holder issues a letter of authorisation.
What do the historical Celecoxib records mean?
3 organisations have only inactive Type II DMFs for Celecoxib. An inactive DMF records that a filing once existed; it does not show that the organisation supplies the substance today.
Does Celecoxib have a European Certificate of Suitability?
Yes. 26 organisations hold a valid CEP for Celecoxib on the EDQM register, including MATRIX PHARMACORP PRIVATE LIMITED Sangareddy (IN), HARWAY PHARMA CO. LTD. Dongying (CN), HETERO DRUGS LIMITED Hyderabad (IN), AARTI DRUGS LIMITED Mumbai (IN), INTERQUIM S.A. Sant Cugat Del Valles (ES) and DONGBANG FUTURE TECH & LIFE CO., LTD. Hwaseong-Si (KR) and 22 more. A CEP confirms the substance can be controlled by the European Pharmacopoeia monograph; it is not a GMP certificate, and the holder is not necessarily the manufacturer.
Does the FDA Orange Book list patents for products containing Celecoxib?
Yes. The latest patent listed for an approved US product containing Celecoxib expires 17 Sept 2045, across 73 listed products. These patents protect specific products, formulations or uses. They do not by themselves mean the ingredient is protected, and generic versions of other products may already be approved.
How do I qualify a Celecoxib supplier?
Confirm the DMF or CEP is current and covers your grade, obtain the letter of authorisation, identify the actual manufacturing site and check its GMP certificate and FDA inspection history, audit the site or review a recent audit, and run comparable requests for information across more than one candidate.
Do you supply Celecoxib?
Send a link to a certificate, registration or filing we have missed or got wrong. We check it against the issuing register before changing anything; information we cannot check against a register is shown as supplier-reported.